Background: Preclinical studies have hypothesized a possible immunological reponse to allogeneic materials due to detection of remnants of potential immunogenic molecules. However, their impact on integration, bone remodeling and immunological reaction after the augmentation procedure is largely unknown and a direct correlation of analytical data and evaluation of human biopsies is missing.
| INTRODUCTION
Loss of bone volume leading to alveolar atrophy results from different pathogenic processes related to tooth loss, periodontitis, dental trauma, or tumors. 1 Dimensional changes of the alveolar ridge often lead to unfavorable local conditions, for example, for implant placement. Therefore, bone grafting in order to obtain sufficient bone volume is one of the most widespread administered therapies in oral and maxillofacial surgery. 2 Autologous bone application is still considered the gold standard, 3, 4 although this technique can be associated with several disadvantages, for example, donor site morbidity, pain, impaired function or limitations in quantity and quality of available bone. 5 In recent years, the use of allogeneic human bone has been favored worldwide, and the number of reports of its use for several indications in oral surgery is increasing. 6, 7 This may be due to superior remodeling potential compared to xenogenic materials and increasing safety guidelines regarding standardized procedures for the screening of donors as well as harvesting, processing, and storing of allogeneic human bone. Extensive serological screening for potential infectious diseases, graft sterilization and establishment of a global biovigilance programme in combination with a long-term traceability of allografts have significantly improved safety, resulting only in a theoretical risk of transmission, for example, human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) today. 6, 8, 9 Recent evidence for the detection of cellular remnants, such as cartilage tissues, cells or proteins in allogeneic substitutes, 10, 11 raised the question if immunological side effects may occur, resulting for example in sensitization 12 against the allogeneic substitute. In a very recent study, Fretwurst et al. showed that major histocompatibility complex molecules (MHC) were detectable in allogeneic bone blocks.
The authors conclude that despite thorough processing, a potential antigenicity might not be totally eliminated in allografts, probably inducing a T cell-mediated immune response against the allograft. 13 Due to the controversial discussion of immunological aspects in allogeneic graft healing, in the present study the hypothesis was tested whether MHC molecules can be detected in both materials tested, a solvent dehydrated allogeneic material from a single donor (Puros Allograft) and in a freeze-dried material pooled from multiple donors (Maxgraft), eliciting an immunological response in the patients. Therefore, five different batches of each material were screened for soluble protein content and residues of MHC molecules according to methods reported previously. 13 The patients receiving those allografts were clinically closely monitored for signs of inflammatory reactions. Furthermore, biopsy cores were harvested prior to implant placement and analyzed using histological and immunohistochemical methods in order to relate these findings to potential signs of inflammation, T-cell mediated cellular reactions or other histological signs indicating adverse effects on graft incorporation in the human recipients. As a secondary objective we also analyzed the healing of the grafts histomorphometrically and histologically by investigating anabolic and catabolic immunohistochemical markers for bone remodeling in order to explore influences of probable inflammation on osteogenesis.
| MATERIALS AND METHODS

| Study design, bone allograft material, and participants
As a randomized clinical trial, the publication was written on the basis of CONSORT guidelines. 14 Alveolar ridge defects were classified according to the index published by Seibert in 1983. 15 Only patients with Seibert class I defects were included in the present study. Lateral augmentation procedures of the alveolar ridge were performed in a parallel trial design in a two-stage surgery with two different commercially available particulate allograft materials that were rehydrated in the second phase of the PRGF system (PRGF-2; BTI, Vittoria, Spain) and the same type of collagen membranes. Ten patients for each group were randomly assigned to the type of bone grafting material by a blinded clinician not involved in this study and not involved in the periodontal office by drawing sealed envelopes. As allografts for guided bone regeneration, we used Maxgraft Allograft Spongiosa Particle (botiss biomaterials GmbH, Berlin, Germany, part of Straumann Group, Basel, Switzerland) or Puros Allograft Spongiosa Particle (Zimmer Biomet, Warsaw, Indiana) each in 10 of 20 individuals included in this study. If more than one implant was placed in one patient, only one biopsy was taken for histological analysis in order to prevent bias due to multiple biopsy analysis from one individual. Both bone grafting materials are treated in a multistep chemical cleaning process to inactivate potential pathogens. Maxgraft is a pooled allogeneic material from multiple donors and finally dehydrated by freeze-drying, whereas Puros is an allogeneic material harvested from one single donor per batch and is dehydrated using a solvent dehydration process prior to packaging and gamma-irradiation. Each process has been validated to inactivate viruses and bacteria and preserve the natural collagen-bone mineral composition which prevents disease transmission by removing and/or inactivating cells, viruses, antigens, and pathogens. 16 Biopsy collection and experiments were performed in compliance with the World Medical Association Declaration of Helsinki (version 2008) and were approved by an ethics committee (Hamburg Medical Association, Germany, no. PV5211) and the study was registered with the German Register for Clinical Trials (DRKS no.: 00013010). All patients gave their informed consent and all patients completed the study successfully and were available for follow-up visits. No adverse events were recorded. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Consent was obtained from all patients for publication of this study and any accompanying images.
| Surgical procedure
Grafting and subsequent implant placement was performed under local anesthesia using Ultracain-DS Forte (Sanofi-Aventis, Frankfurt/Main, Germany). Prior to surgical intervention, venous blood was collected from the patients for preparation of plasma rich in growth factors (PRGF) according to the manufacturer's specifications using the PRGF-Endoret technology (BTI, Miñano, Spain). PRGF was added to both of the previously in sterile saline rehydrated allogeneic graft materials in order to improve postoperative healing. 17 After deflection of a mucoperiosteal flap ( Figure 1A) , a cortical perforation was done ( Figure 1B) , and bone grafting material was inserted ( Figure 1C ). The allografts were covered with a Jason membrane for guided bone regeneration, according to the manufacturer's recommendations (botiss biomaterials GmbH, Zossen, Germany) ( Figure 1D Figure 1G ). Two-dimensional radiographs, using the parralleling technique with a Rinn holder (Dentsply Rinn, Smile WayYork, Pennsylvania) were taken immediately following the bone augmentation procedure (not shown), immediately after implant insertion (not shown), and after final prosthetic reconstruction in order to visualize the final result as a baseline for future radiographic comparison ( Figure 1H ).
| Protein extraction
Extraction of proteins was performed as previously reported. 13 We dialyzed 4 × 150 mg bone material of each allograft batch using the Slide A Lyzer Mini Dialysis Filter Devices 3.5 kDa (Thermo Fisher Scientific, Darmstadt, Germany), corresponding to the manufacturer's protocol. Briefly, 44.5 mL PBS (phosphate buffered saline) were filled in the part below the filter of the device. After wetting the filter with 4 mL PBS, 2 mL lysis buffer (0.3 M sucrose, 10 mM Tris pH 7.5, 5 mM MgCl 2 , 1% Triton X-100) and 150 mg bone material were added to the filter device. Three incubation steps were performed for 2 hours, overnight and 2 hours by orbital shaking at 200 rpm, 4 C. To narrow the volume, the pooled dialyzed (about 10 mL) protein extract of each batch was added to the Amicon Ultra-4 10 K Centrifugal Filter Device (Merck, Darmstadt, Germany) and centrifuged twice at 4000g, 4 C for 20 minutes. Protein concentration was determined spectrophotometrically using the Qubit Protein Assay kit (Thermo Fisher Scientific).
| ELISA measurements for detection of MHC1
To perform the ELISA, leukocytes served as a positive control. Leukocytes were extracted from 7.5 mL EDTA blood with 750 μL lysis buffer. After incubation on ice for 5 minutes and centrifugation at 400g, 4 C for 5 minutes, the pellet contained leukocytes and residues of erythrocytes.
Incubation of the pellet with 1.5 mL lysis buffer on ice for 5 minutes and centrifugation at 400g, 4 C for 5 minutes were repeated until the erythrocytes were completely removed from the leukocyte pellet. Then the purified leukocyte pellet was resuspended in 1 mL PBS and centrifuged at 400g, 4 C for 5 minutes. These washing steps were repeated three times. 
| Histology
Each biopsy sample was fixed by immersion in 4% buffered formaldehyde (Sörensen buffer) at room temperature (RT) for at least 1 day and subsequently decalcified for about 2 to 3 weeks in 4.1% disodium ethylenediaminetetraacetic acid (EDTA) solution, which was changed every 24 hours. After hydration, tissues were dehydrated in an ascending series of ethanol and embedded in paraffin. Serial longitudinal sections of 2 to 3 μm were cut and representative slides were stained with hematoxylin-eosin (HE). In order to identify osteoclasts, selected tissue sections were stained for tartrate-resistant acid phosphatase (TRAP).
| Immunohistochemistry
Representative slides from the median parts of the sample series were deparaffinized, rehydrated and rinsed for 10 minutes in tris-buffered saline (TBS). Endogenous peroxidase was blocked in a methanol/H 2 O 2 (Merck, Darmstadt, Germany) solution for 45 minutes in the dark. Sections were pretreated with PBS containing 1% bovine serum albumin (BSA) for 20 minutes at RT, digested with 0.4% pepsin for 10 minutes at 37 C and then incubated with the primary antibodies in a humid chamber. The following markers were investigated: bone matrix and differentiation markers (alkaline phosphatase [ALP], osteocalcin [OC], osteopontin F I G U R E 1 Overview of the surgical procedure. A very thin alveolar crest appeared after reflection of a mucoperiosteal flap (A). The alveolar ridge was then prepared with cortical perforations (B). Thereafter, the bone allograft material soaked in the second phase of the PRGF solution was applied in order to build up the alveolar bone volume necessary for future implant placement (C). It was then covered with a resorbable collagen membrane (D). The surgical site was primarily closed by means of a periosteal incision (E), the use of horizontal mattress sutures and a continuous half-hitch suture. The second surgical procedure took place after a healing period of 4 months. The significant gain in alveolar ridge volume can be appreciated (F). Four implants were placed according to the manufacturer's recommendations (Straumann Group, Basel Switzerland). Four months later, the implants were uncovered (G). Postoperative two-dimensional radiographs demonstrate stable integration of the implants 36 months after final restauration (H)
[OP], [runx2]), immunological markers (CD3, CD4, CD8, and ED1), and the vessel marker von Willebrand factor (vWF). Collagen type I was also stained. Antibody details and incubation protocols are listed in Table 1 .
Antibody binding was detected with the peroxidase-conjugated EnVision anti-mouse system or the EnVision anti-rabbit/anti-goat HRPconjugated secondary antibodies (Dako, Glostrup, Denmark), diluted 
| Histological and immunohistochemical evaluation
Histological specimens were evaluated qualitatively and semi-quantitatively on the basis of established scoring methods in bone histology and pathology 19 or own published methods as well as methods from the literature on certain parameters investigated in similar studies on the healing of bone replacement materials. [20] [21] [22] The assessment was always per- 
| Histomorphometrical analysis
Histomorphometrical analysis was conducted with Leica Application Suite (LAS) software (Leica Microsystems GmbH). The areas to be measured were bypassed using area measurement, and the results were stored in the LAS report and calculated as percentages using Excel.
| Statistical analysis
Due to the prospectice randomized nature of this clinical trial in a private practice setting the pre-specified statistical null hypothesis, that 3 | RESULTS
| Patient demographics and characteristics
Patient demographics and characteristics are summarized in Table 2 
| Clinical findings
After the healing period, all augmented areas in all patients showed a sufficient bone volume during the re-entry for biopsy retrieval and 
| Protein measurements and results of the MHC1 ELISA
Measurements of the soluble protein content in the tested graft materials revealed concentrations ranging from 0.38 to 1.50 μg/mg dry mass (Maxgraft) and 0.47 to 1.70 μg/mg dry mass (Puros) ( Table 3 ).
Using the MHC1 ELISA method, no MHC1 antigens could be detected in any allograft sample tested, whereas high concentrations of MHC1 could be measured in leukocytes, which served as a positive control (data not shown).
| Histological, histochemical, and immunohistochemical findings
Representative overviews of biopsies are shown as Figures S1-S4.
In lower magnification, the core biopsies appeared as cylindrical specimens composed of mostly cancellous bone consisting of interconnected trabecules of different diameters, allogeneic granules, and intertrabecular connective tissue ( Figure 2 ). Artificial ecchymosis and bone or connective tissue fragmentation due to trephanation could be observed in nearly all specimens. All biopsies showed the formation of a network of cancellous bony trabeculae by appositional membranaceous osteogenesis of different stages around or connecting allogenic particles or larger spongy or even compact ossicles with minor or no allogenic remnants (Figure 2A-F) . Allogenic particles from both manufacturers could be clearly identified as mostly basophilic lamellar bone fragments containing empty osteocyte lacunae (Figure 2A,B,E) . Only very occasionally, organic remnants in these lacunae could be identified for both types of material. Freshly formed bone was of fibrous type. Most surfaces of newly formed bone were covered by osteoblasts with underlying osteoid. In some specimens, fibrous bone was already remodeled into mature cancellous or compact bone appearing as lamellar bone with fibrous bone remnants incorporated ( Figure 2C,D) . The bone surfaces were covered by lining cells. Focally, allogenic remnants of different sizes were embedded in new bone (Figure 2A,B and moderate to strong vascularization ( Figure 2B ,C,D). Osteoclasts appeared on the surface of newly formed bone and allogenic granules.
No foreign body giant cells were detected. Infiltrations were observed in six specimens equally distributed to both groups and mostly appeared as small areas of loose round cell aggregations located in the connective intertrabecular tissue or at the periphery of the specimens (Figure 2E,F) . Semi-quantitatively, osteogenesis was mostly graded as 2 or 3 on the scale, while infiltration was judged as not present or grade 1 in the majority of patients (Table 4 ).
TRAP-positive osteoclasts were localized on the surfaces of newly formed bone but also of allogenic particles (Figure 3A,B) . In the specimens of four patients, no TRAP activity was visible. Focally osteoblasts, lining cells and a few fibroblasts showed immunoreactivity for ALP in nearly all specimens (Figure 3c,d) . CD3-positive lymphocytes could be detected in eight of the specimens investigated. Most of the CD3-positive cells were found within infiltrates or perivascularly ( Figure 3G,H) . CD4-positive lymphocytes were seen in only three of the investigated specimens. In one case, they were located within an infiltration; in two cases, aggregation was observed close to bone surfaces ( Figure 3E,F) . For CD8, only one case showed few positive lymphocytes within an infiltration.
COL I immunostaining in a weak to moderate manner could be seen in the matrix of newly formed bone with stronger staining in osteoid seams and osteocytes in most cases. Focally, osteoblasts were immunoreactive ( Figure 4A,B) . Additionally, connective tissue staining could be observed. COL I was not present in allogenic particles ( Figure 4C,D) .
All osteoclasts showed ED1 immunoreactivity. Additionally, macrophages were positive. (Figure 4E,F) .
The newly formed bone matrix showed weak OC immunostaining, while most osteoblasts, osteocytes and some fibroblasts near to bone surfaces were stained more intensively. Also, interfaces between allogenic particles and newly formed bone were reactive ( Figure 5A,B) .
Immunoreactivity for OP was weak or absent. Focally, connective tissue areas and interfaces between allogenic material and newly formed bone were stained ( Figure 5C,D) .
In terms of runx2, immunoreactive cells were observed only in eight of the total cases. Staining was restricted to osteoblasts and lining cells and some fibroblasts near to bone surfaces ( Figure 5E,F) .
Staining for vWF revealed a moderate to good vessel density in most of the specimens. Capillaries, small arterioles, and large sinuosoids were the predominant vessel type located between the bone trabecules and allogenic granules (Figure 5g,h) .
The statistical evaluation of the histological and immunohistochemical findings that are listed in Table 4 did not reveal any significant differences between the allografts tested. Table 5 ), largely due to heterogenous findings within the individual groups.
| Histomorphometrical findings
| DISCUSSION
Histologically and immunohistochemically, there were only minor signs of an inflammatory reaction in both groups. Small cellular infiltrations, as seen in some specimens investigated, may be due to transient weak inflammatory reactions, which are considered to be part of the normal process of bone fracture and bone substitute healing. 23, 24 Especially CD4+ T-cells, which we detected in some of our specimens ( Figure 3) , are involved in bone healing and remodeling. 25, 26 Immunohistochemical findings for vWF showed a good vascularization of the augmented areas for both allogeneic grafts ( Figure 5 ).
Further indications for the lack of antigenicity of the materials used are evident from the histological observations: nearly no proteinaceous remnants, for example, osteocyte remnants, could be observed and the graft granules showed no collagen type I as revealed by immunohistochemistry. Furthermore, multinucleated foreign body giant cells as it was reported after application of an allogeneic spongious bone block (Tutobone) for alveolar ridge augmentation, 27 were not observed in our study. Other authors reported that MHC molecules have been detected in some but not all allogeneic bone blocks processed by peracetic-acid-ethanol-sterilization (PES) and the authors elucidated the significance of such remnants on graft incorporation and long-term survival. 13 PES treatment has been extensively validated and was classified as an effective and safe processing method. 28, 29 Transplants sterilized by this method have been in clinical use for decades. A retrospective study following up on several thousand recipients of large transplants in orthopedic surgery including cortical and cancellous bone, tendon, amniotic membrane, and skin confirmed not only excellent primary integration, but also lack of late complications or even rejections. 30 This may suggest that trace amounts of MHC molecules are clinically not relevant. Despite the frequent use of human tissue products worldwide in a variety of medical specialties, formation of alloantibodies complicating future solid organ transplantation has rarely been reported for fresh-frozen or cryopreserved bone. 12, 31 After using freeze-dried or solvent dehydrated bone allografts from single or multiple donors for dental applications, such incidences have not been reported at all. In our study, we did not detect any MHC1 molecules in the individual batches of bone allograft materials using ELISA.
According to the findings for TRAP histochemistry and ED1 immunohistochemistry, both allogeneic materials are resorbed by osteoclasts located on the surface of graft particles. Since in the present study there was no evidence for the occurrence of larger multinucleated cells indicating a foreign body reaction, as it was observed after augmentation with allogeneic cancellous bone blocks (Puros), 27 these findings may lead to the assumption that the efficiency of decellularization negatively correlates with the size of the allograft that is subject to chemical processing. In other words, cellular remnants are fewer in particulate material than in solid blocks.
Although the procedures remove the vast majority of cellular matter, denatured traces can be detected. 11 As shown by thermogravimetric measurements, Maxgraft only contains around 62% anorganic matter, while the rest is composed of residual moisture (~5%) and natural bone proteins resulting in improved biomechanical properties compared to purely anorganic materials. 32 While ED1 marks all macrophages and osteoclasts, TRAP staining is also a functional marker for resorptive osteoclast activity. This may explain the missing TRAP staining in sections from a subgroup of our patients (Table 4 ), indicating insufficient activity or maturity of the osteoclasts during the period of biopsy harvesting. 33 The detection of TRAP-positive osteoclasts, which are also found on the surfaces of newly formed bone, indicates an ongoing remodeling process. Resorption of allogeneic graft materials is considered to be slower than that of autogenous bone but faster than that of xenogeneic and alloplastic substitutes. 34 The bone grafting materials used in our study were allogeneic mineralized bone grafts, which have shown a progressive transformation into vital new bone. After a mean healing period of 5.0 months, bone replacement materials were either converted or incorporated into vital new bone. We are aware of the fact that studying only 10 subjects per grafting material does not allow for a generalized statement, but our work may serve as a clinical pilot study with a promising outcome The histological findings for both materials tested in this study showed similar processes typical for osteoconductive phenomena of bone healing: membranaceous osteogenesis around allogenic graft material forming a bony cancellous network, remodeling of the newly formed bone from fibrous into mature lamellar bone tissue, degradation of the graft by osteoclastic activity. Furthermore, no significant differences between the investigated grafting materials could be found histomorphometrically (Table 5) fragments with empty osteocyte lacunae histologically. This histological picture resembled that of other histological studies in humans on the healing of different allograft materials. [42] [43] [44] [45] [46] [47] Similar findings could also be obtained in animal studies, although they are not directly comparable with the human situation as any use of human-derived material in animals is classified as xenogeneic. Additionally, the clinical procedures in most animal studies using human bone grafts have been undertaken in long bones or for critical size defects in jaw bones. 48 In both groups, no abnormal tissues like cartilage or pathological alterations like necrosis or microbes could be seen histologically, except for the usual artifacts due to trephination ( Figures S1-S4 ). This was in contrast to a study using fresh-frozen cortical and cortico-cancellous allogeneic block grafts for augmentation of the anterior maxilla, which found necrotic areas as well as reduced incorporation, remodeling, and increased resorption of these grafts. 49 There are only very few studies comparing histomorphometric data obtained after sinus lift procedures using allogeneic bone substi- 47 Recently, a study on 14 patients calculated 18.65% of new bone when using allogeneic spongious bone blocks (Tutobone) for vertical and horizontal ridge augmentation prior to implant placement. 27 As mentioned above, a direct comparison to our study is not possible since we used those materials for lateral ridge augmentation. Another factor that may be responsible for the heterogenous findings in the present study could be the addition of PRGF after rehydration. It remains unclear how even the distribution of particulate material and PRGF was established within the grafting material in the individual patient and especially when comparing multiple patients. Since PRGF has been applied as a supplement for the grafts in both groups, we cannot give any statement concerning a specific influence of this fibrin preparation on the graft and wound healing. However, there are indications from pre-clinical and clinical studies as well as systematic reviews that PRGF may improve bone healing. 17, 52, 53 For osteogenic markers, no obvious differences in their immunostaining pattern and intensity could be obtained between biopsies of both grafts. Runx2, ALP, COL 1, OC, and OP are cellular and bone matrix marker proteins, that reflect increasing stages of osteogenesis and bone tissue formation, which have been detected during bone substitute healing. 40, 41 In a rabbit experiment using bone allograft for critical size defects, an increasing immunostaining for these markers was found 48 and those staining patterns were similar to our findings.
These osteogenic markers were also upregulated in a mouse calvarium defect model using human DFDBA, where gene expression was investigated after 1 and 3 months of healing. 54 From allograft studies in rhesus monkeys, it is known that non-decalcified freeze-dried human allograft is superior to decalcified allografts in stimulating new bone formation. 55 OC-immunoreactive cells were also observed after application of fresh frozen bone for sinus lift after 6 months. 56 As mentioned before, the current study is limited by its low sample size. Therefore, the statistical findings should be viewed critically.
To support our statistical data, analyses of larger sample sizes are required and planned. Nevertheless, our data indicate no significant differences between the Maxgraft and the Puros group for all parameters and a similar biological behavior after implantation. 
| CONCLUSION
